Trials / Recruiting
RecruitingNCT05089747
CIRculating CANcer MAster-Protocol
MAster Protocol Studying the Impact of Blood Biopsy on Screening, Diagnosis, Diagnostic and Follow-up of Solid Cancer in Adult
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 6,000 (estimated)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This exploratory study will focus on the development of the analyses of blood biomarkers to better understand the circulating biomarkers associated with cancer diagnosis, treatment efficacy and progressive disease
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Blood sampling for biomarker analysis (microRNA, circulating DNA…) | From one to four blood samplings: at diagnosis, after the first cycle of treatment, end of treatment, progressive disease (or end of study). |
Timeline
- Start date
- 2022-12-05
- Primary completion
- 2047-12-01
- Completion
- 2047-12-01
- First posted
- 2021-10-22
- Last updated
- 2023-07-24
Locations
5 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05089747. Inclusion in this directory is not an endorsement.